BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34454531)

  • 1. Calibrated automated thrombogram II: removing barriers for thrombin generation measurements.
    Giesen PLA; Gulpen AJW; van Oerle R; Ten Cate H; Nagy M; Spronk HMH
    Thromb J; 2021 Aug; 19(1):60. PubMed ID: 34454531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system.
    Pfrepper C; Metze M; Siegemund A; Klöter T; Siegemund T; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):619-627. PubMed ID: 32548561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant Activity of Nucleic Acid Nanoparticles (NANPs) Assessed by Thrombin Generation Dynamics on a Fully Automated System.
    de Freitas Saito R; Barion BG; da Rocha TRF; Rolband A; Afonin KA; Chammas R
    Methods Mol Biol; 2023; 2709():319-332. PubMed ID: 37572292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation measured on ST Genesia, a new platform in the coagulation routine lab: Assessment of analytical and between-subject variation.
    Kristensen SR; Nybo J; Pedersen S
    Res Pract Thromb Haemost; 2022 Jan; 6(1):e12654. PubMed ID: 35128301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis.
    Taune VS; Zabczyk M; He S; Ågren A; Blombäck M; Wallén H; Skeppholm M
    Scand J Clin Lab Invest; 2024 Jul; ():1-11. PubMed ID: 38953609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability.
    Calzavarini S; Brodard J; Quarroz C; Maire L; Nützi R; Jankovic J; Rotondo LC; Giabbani E; Fiedler GM; Nagler M; Angelillo-Scherrer A
    Res Pract Thromb Haemost; 2019 Oct; 3(4):758-768. PubMed ID: 31624796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants.
    Metze M; Pfrepper C; Klöter T; Stöbe S; Siegemund R; Siegemund T; Edel E; Laufs U; Petros S
    Res Pract Thromb Haemost; 2020 May; 4(4):610-618. PubMed ID: 32548560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study.
    Brodard J; Calzavarini S; Quarroz C; Berzigotti A; De Gottardi A; Angelillo-Scherrer A
    Thromb Res; 2021 Nov; 207():40-49. PubMed ID: 34536665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay.
    D'Alessandro E; Scaf B; van Oerle R; van Nieuwenhoven FA; van Hunnik A; Verheule S; Schotten U; Ten Cate H; Spronk HMH
    Res Pract Thromb Haemost; 2021 Dec; 5(8):e12620. PubMed ID: 34849448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global coagulation assays detect an early prothrombotic state in children with acute lymphoblastic leukemia.
    Betticher C; Bertaggia Calderara D; Matthey Guirao E; Gomez FJ; Aliotta A; Lemmel E; Ceppi F; Alberio L; Rizzi M
    J Thromb Haemost; 2024 Jun; ():. PubMed ID: 38897386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm.
    Jackson JW; Longstaff C; Woodle SA; Chang WC; Ovanesov MV
    Thromb J; 2023 Oct; 21(1):104. PubMed ID: 37794418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of therapeutic plasma exchange on intact protein S, apolipoproteins, and thrombin generation.
    Pitkänen HH; Haapio M; Saarela M; Taskinen MR; Brinkman HJ; Lassila R
    Transfus Apher Sci; 2024 Jun; 63(3):103918. PubMed ID: 38555232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.
    Ninivaggi M; de Laat-Kremers RMW; Carlo A; de Laat B
    Res Pract Thromb Haemost; 2021 Jan; 5(1):187-196. PubMed ID: 33537543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of thrombin generation platforms for patients with coagulation factor deficiencies: A comprehensive assessment.
    Haisma B; Schols SEM; van Oerle RGM; Verbeek-Knobbe K; Hellenbrand D; Verwoerd EJ; Heubel-Moenen FCJI; Stroobants AK; Meijer D; Rijpma SR; Henskens YMC
    Thromb Res; 2024 May; 240():109045. PubMed ID: 38834002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review.
    Zwaveling S; Bloemen S; de Laat B; Ten Cate H; Ten Cate-Hoek A
    TH Open; 2018 Jul; 2(3):e291-e302. PubMed ID: 31249953
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the utility of a novel point-of-care whole blood thrombin generation assay following trauma: A pilot study.
    Ferrara MJ; MacArthur TA; Butenas S; Mann KG; Immermann JM; Spears GM; Bailey KR; Kozar RA; Heller SF; Loomis EA; Stephens D; Park MS
    Res Pract Thromb Haemost; 2021 Mar; 5(3):395-402. PubMed ID: 33870025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INHIBITORS OF INORGANIC POLYPHOSPHATE AND NUCLEIC ACIDS ATTENUATE IN VITRO THROMBIN GENERATION IN PLASMA FROM TRAUMA PATIENTS.
    MacArthur TA; Goswami J; Navarro SM; Vappala S; La CC; Yudin N; Zietlow J; Smith SA; Morrissey JH; Spears GM; Bailey KR; Dong JF; Kozar RA; Kizhakkedathu JN; Park MS
    Shock; 2024 Jun; 61(6):848-854. PubMed ID: 38662595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pH on thrombin generation-An unrecognized potential source of variation.
    Kristensen SR; Nybo J; Pedersen S
    Res Pract Thromb Haemost; 2020 Feb; 4(2):224-229. PubMed ID: 32110752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological variation of thrombin generation on ST Genesia.
    van Dievoet MA; Morimont L; Bouvy C; Gruson D; Stephenne X; Douxfils J
    Int J Lab Hematol; 2024 Jun; 46(3):564-567. PubMed ID: 38253351
    [No Abstract]   [Full Text] [Related]  

  • 20. A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease.
    Starr JA; Pinner NA; Mannis M; Stuart MK
    Ann Pharmacother; 2022 Jun; 56(6):691-703. PubMed ID: 34459281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.